NCR Atleos (NATL) Financials

$44.54 -0.52 (-1.15%)

As of 05/15/2026 03:58 PM Eastern

Annual Income Statements for NCR Atleos

This table shows NCR Atleos' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024	2025
Period end date	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	99	-150	80	162
Consolidated Net Income / (Loss)	98	-148	81	162
Net Income / (Loss) Continuing Operations	-7.00	-242	81	162
Total Pre-Tax Income	146	89	125	189
Total Operating Income	258	263	437	478
Total Gross Profit	803	834	1,020	1,061
Total Revenue	4,122	4,186	4,305	4,354
Operating Revenue	4,122	4,186	4,305	4,354
Total Cost of Revenue	3,319	3,352	3,285	3,293
Operating Cost of Revenue	3,319	3,352	3,285	3,293
Total Operating Expenses	650	665	583	583
Selling, General & Admin Expense	586	585	521	513
Research & Development Expense	64	80	62	70
Total Other Income / (Expense), net	-112	-174	-312	-289
Interest Expense	31	90	333	270
Other Income / (Expense), net	-81	-84	21	-19
Income Tax Expense	48	237	44	27
Net Income / (Loss) Attributable to Noncontrolling Interest	-1.00	2.00	1.00	0.00
Basic Earnings per Share	$1.40	($2.12)	$1.11	$2.20
Weighted Average Basic Shares Outstanding	70.60M	70.60M	72.20M	73.50M
Diluted Earnings per Share	$1.40	($2.12)	$1.08	$2.14
Weighted Average Diluted Shares Outstanding	70.60M	70.60M	74.20M	75.60M
Weighted Average Basic & Diluted Shares Outstanding	-	-	73.04M	73.56M

This table shows NCR Atleos' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	-58	-181	-8.00	30	21	34	14	45	26	74	22
Consolidated Net Income / (Loss)	-57	-180	-8.00	29	20	37	13	44	26	76	22
Net Income / (Loss) Continuing Operations	-91	-185	-8.00	29	20	37	13	44	26	76	22
Total Pre-Tax Income	90	-138	-4.00	33	30	59	22	63	33	67	33
Total Operating Income	91	27	72	108	114	138	93	120	110	152	84
Total Gross Profit	234	193	221	251	256	286	232	253	271	302	234
Total Revenue	1,067	1,093	1,050	1,080	1,073	1,097	979	1,104	1,121	1,149	1,043
Operating Revenue	1,067	1,093	1,050	1,080	1,073	1,097	979	1,104	1,121	1,149	1,043
Total Cost of Revenue	833	900	829	829	817	811	747	851	850	847	809
Operating Cost of Revenue	833	900	829	829	817	811	747	851	850	847	809
Total Operating Expenses	177	166	149	143	142	148	139	133	161	150	150
Selling, General & Admin Expense	160	140	132	132	127	130	122	116	143	132	130
Research & Development Expense	17	26	17	11	15	18	17	17	18	18	20
Total Other Income / (Expense), net	-1.00	-170	-76	-75	-84	-79	-71	-57	-77	-85	-51
Interest Expense	6.00	-	79	79	79	96	67	69	68	66	63
Other Income / (Expense), net	5.00	-90	3.00	4.00	-5.00	17	-4.00	12	-9.00	-19	12
Income Tax Expense	147	42	4.00	4.00	10	22	9.00	19	7.00	-9.00	11
Net Income / (Loss) Attributable to Noncontrolling Interest	1.00	1.00	0.00	-1.00	-1.00	3.00	-1.00	-1.00	0.00	2.00	0.00
Basic Earnings per Share	($0.82)	($2.56)	($0.11)	$0.42	$0.29	$0.47	$0.19	$0.61	$0.35	$1.01	$0.30
Weighted Average Basic Shares Outstanding	70.60M	70.60M	71.60M	72.20M	72.30M	72.20M	73.10M	73.50M	73.70M	73.50M	73.60M
Diluted Earnings per Share	($0.82)	($2.56)	($0.11)	$0.41	$0.28	$0.46	$0.19	$0.60	$0.34	$0.97	$0.29
Weighted Average Diluted Shares Outstanding	70.60M	70.60M	71.60M	73.70M	74.50M	74.20M	75.20M	74.90M	76M	75.60M	75.60M
Weighted Average Basic & Diluted Shares Outstanding	-	0.00	72.12M	72.32M	72.49M	73.04M	73.45M	73.59M	73.90M	73.56M	73.78M

This table details how cash moves in and out of NCR Atleos' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024	2025
Period end date	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	40	70	55	3.00
Net Cash From Operating Activities	274	355	344	356
Net Cash From Continuing Operating Activities	274	355	344	356
Net Income / (Loss) Continuing Operations	98	-148	81	162
Consolidated Net Income / (Loss)	98	-148	81	162
Depreciation Expense	127	254	287	277
Non-Cash Adjustments To Reconcile Net Income	118	-97	-7.00	-47
Changes in Operating Assets and Liabilities, net	-201	346	-17	-36
Net Cash From Investing Activities	-417	-316	-135	-116
Net Cash From Continuing Investing Activities	-417	-316	-135	-116
Purchase of Property, Plant & Equipment	-97	-132	-126	-156
Acquisitions	-78	-1.00	-13	-17
Purchase of Investments	0.00	-10	4.00	1.00
Sale of Property, Plant & Equipment	-	0.00	0.00	45
Divestitures	0.00	0.00	1.00	11
Other Investing Activities, net	-242	-173	-1.00	0.00
Net Cash From Financing Activities	183	31	-134	-253
Net Cash From Continuing Financing Activities	183	31	-134	-253
Repayment of Debt	-604	-541	-1,519	-1,172
Repurchase of Common Equity	-	0.00	0.00	-28
Issuance of Debt	68	3,636	1,404	976
Issuance of Common Equity	0.00	0.00	4.00	11
Other Financing Activities, net	719	-3,064	-23	-40
Effect of Exchange Rate Changes	-	-	-20	16

This table details how cash moves in and out of NCR Atleos' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	2,152	-2,137	21	23	54	-43	41	-32	-63	57	-48
Net Cash From Operating Activities	147	8.00	148	9.00	107	80	123	-23	25	231	-9.00
Net Cash From Continuing Operating Activities	147	8.00	148	9.00	107	81	123	-23	25	231	-9.00
Net Income / (Loss) Continuing Operations	-57	-180	-8.00	30	15	38	13	42	19	85	22
Consolidated Net Income / (Loss)	-57	-180	-8.00	30	15	38	13	42	19	85	22
Depreciation Expense	34	36	73	71	74	35	69	72	70	66	70
Non-Cash Adjustments To Reconcile Net Income	-4.00	-130	-2.00	-	9.00	-	1.00	-24	-14	-10	-11
Changes in Operating Assets and Liabilities, net	145	247	85	-92	9.00	-26	40	-113	-50	90	-90
Net Cash From Investing Activities	-254	-47	-31	-40	-39	-25	-37	-	-51	-28	-25
Net Cash From Continuing Investing Activities	-254	-47	-31	-40	-39	-25	-37	-	-51	-28	-25
Purchase of Property, Plant & Equipment	-48	-47	-30	-32	-33	-31	-41	-35	-43	-37	-37
Purchase of Investments	-	-	0.00	-	-1.00	-	4.00	-	-3.00	-	0.00
Divestitures	-	-	-	-	-	-	0.00	-	-	-	12
Net Cash From Financing Activities	2,259	-2,098	-87	57	-19	-85	-49	-17	-36	-151	-11
Net Cash From Continuing Financing Activities	2,259	-2,098	-87	57	-19	-85	-49	-17	-36	-151	-11
Repayment of Debt	-257	-227	-155	-395	-401	-568	-175	-312	-356	-329	-239
Repurchase of Common Equity	-	-	-	-	-	-	0.00	-	-	-	-16
Issuance of Debt	2,202	1,418	74	459	386	485	150	290	321	215	260
Other Financing Activities, net	314	-3,289	-6.00	-8.00	-6.00	-3.00	-24	-2.00	-1.00	-13	-16
Effect of Exchange Rate Changes	-	-	-9.00	-3.00	5.00	-	4.00	8.00	-1.00	5.00	-3.00

This table presents NCR Atleos' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2023	2024	2025
Period end date	12/31/2023	12/31/2024	12/31/2025
Total Assets	5,702	5,535	5,668
Total Current Assets	1,861	1,749	1,824
Cash & Equivalents	339	419	456
Restricted Cash	238	210	175
Accounts Receivable	707	581	550
Inventories, net	333	307	342
Other Current Assets	244	232	301
Plant, Property, & Equipment, net	468	474	511
Total Noncurrent Assets	3,373	3,312	3,333
Goodwill	1,952	1,950	1,958
Intangible Assets	635	550	498
Noncurrent Deferred & Refundable Income Taxes	254	285	288
Employee Benefit Assets	219	227	259
Other Noncurrent Operating Assets	313	300	330
Total Liabilities & Shareholders' Equity	5,702	5,535	5,668
Total Liabilities	5,480	5,312	5,266
Total Current Liabilities	1,773	1,722	1,899
Short-Term Debt	76	81	86
Accounts Payable	505	564	617
Current Deferred Revenue	332	328	383
Current Employee Benefit Liabilities	149	145	139
Other Current Liabilities	711	604	674
Total Noncurrent Liabilities	3,707	3,590	3,367
Long-Term Debt	2,938	2,859	2,672
Noncurrent Deferred Revenue	36	37	24
Noncurrent Deferred & Payable Income Tax Liabilities	34	40	41
Noncurrent Employee Benefit Liabilities	449	424	356
Other Noncurrent Operating Liabilities	250	230	274
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	222	223	402
Total Preferred & Common Equity	219	219	403
Preferred Stock	0.00	0.00	0.00
Total Common Equity	219	219	403
Common Stock	13	48	66
Retained Earnings	117	188	299
Accumulated Other Comprehensive Income / (Loss)	89	-17	38
Noncontrolling Interest	3.00	4.00	-1.00

This table presents NCR Atleos' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	5,776	5,765	5,748	5,739	5,814	5,650	5,641
Total Current Assets	1,983	1,979	1,931	1,937	1,976	1,817	1,815
Cash & Equivalents	343	374	395	352	357	412	433
Restricted Cash	256	249	279	316	279	162	151
Accounts Receivable	742	707	623	658	669	569	575
Inventories, net	330	329	351	356	400	383	366
Other Current Assets	312	320	283	255	271	291	290
Plant, Property, & Equipment, net	461	457	457	479	480	484	509
Total Noncurrent Assets	3,332	3,329	3,360	3,323	3,358	3,349	3,317
Goodwill	1,951	1,951	1,954	1,951	1,953	1,959	1,958
Intangible Assets	606	596	583	553	534	519	474
Noncurrent Deferred & Refundable Income Taxes	253	265	285	297	305	290	283
Employee Benefit Assets	215	221	238	237	261	262	263
Other Noncurrent Operating Assets	307	296	300	285	305	319	339
Total Liabilities & Shareholders' Equity	5,776	5,765	5,748	5,739	5,814	5,650	5,641
Total Liabilities	5,489	5,514	5,486	5,461	5,462	5,319	5,245
Total Current Liabilities	1,883	1,853	1,799	1,888	1,887	1,784	1,851
Short-Term Debt	80	84	88	81	81	80	80
Accounts Payable	530	571	545	542	593	530	597
Current Deferred Revenue	332	318	304	403	395	358	435
Current Employee Benefit Liabilities	132	145	152	120	119	137	106
Other Current Liabilities	809	735	710	742	699	679	633
Total Noncurrent Liabilities	3,606	3,661	3,687	3,573	3,575	3,535	3,394
Long-Term Debt	2,857	2,921	2,906	2,833	2,816	2,789	2,703
Noncurrent Deferred Revenue	36	37	38	37	34	35	24
Noncurrent Deferred & Payable Income Tax Liabilities	29	29	34	47	50	53	41
Noncurrent Employee Benefit Liabilities	447	445	445	425	425	410	358
Other Noncurrent Operating Liabilities	237	229	264	231	250	248	268
Commitments & Contingencies	-	-	-	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	287	251	262	278	352	331	396
Total Preferred & Common Equity	283	250	264	275	350	330	396
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	283	250	264	275	350	330	396
Common Stock	15	24	32	49	56	65	67
Retained Earnings	165	167	191	249	276	268	306
Accumulated Other Comprehensive Income / (Loss)	103	59	41	-23	18	-3.00	23
Noncontrolling Interest	4.00	1.00	-2.00	3.00	2.00	1.00	0.00

This table displays calculated financial ratios and metrics derived from NCR Atleos' official financial filings.

Metric	2022	2023	2024	2025
Period end date	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	-	-	-	73,904,136.00
DEI Adjusted Shares Outstanding	-	-	-	73,904,136.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	2.19
Growth Metrics	-	-	-	-
Revenue Growth	0.00%	1.55%	2.84%	1.14%
EBITDA Growth	0.00%	-0.69%	72.06%	-1.21%
EBIT Growth	0.00%	1.13%	155.87%	0.22%
NOPAT Growth	0.00%	-352.54%	164.75%	44.69%
Net Income Growth	0.00%	-251.02%	154.73%	100.00%
EPS Growth	0.00%	-251.43%	150.94%	98.15%
Operating Cash Flow Growth	0.00%	29.56%	-3.10%	3.49%
Free Cash Flow Firm Growth	0.00%	0.00%	113.18%	1.60%
Invested Capital Growth	0.00%	0.00%	-4.70%	-0.20%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	1.09%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	18.71%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	-5.94%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	30.35%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	28.57%
EPS Q/Q Growth	0.00%	0.00%	0.00%	28.14%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	73.66%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	53.41%
Invested Capital Q/Q Growth	0.00%	0.00%	-1.86%	-3.69%
Profitability Metrics	-	-	-	-
Gross Margin	19.48%	19.92%	23.69%	24.37%
EBITDA Margin	10.58%	10.34%	17.31%	16.90%
Operating Margin	6.26%	6.28%	10.15%	10.98%
EBIT Margin	4.29%	4.28%	10.64%	10.54%
Profit (Net Income) Margin	2.38%	-3.54%	1.88%	3.72%
Tax Burden Percent	67.12%	-166.29%	64.80%	85.71%
Interest Burden Percent	82.49%	49.72%	27.29%	41.18%
Effective Tax Rate	32.88%	266.29%	35.20%	14.29%
Return on Invested Capital (ROIC)	0.00%	-32.90%	10.91%	16.18%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-9.15%	2.39%	5.02%
Return on Net Nonoperating Assets (RNNOA)	0.00%	-100.44%	25.50%	35.66%
Return on Equity (ROE)	0.00%	-133.33%	36.40%	51.84%
Cash Return on Invested Capital (CROIC)	0.00%	-232.90%	15.72%	16.38%
Operating Return on Assets (OROA)	0.00%	3.14%	8.15%	8.19%
Return on Assets (ROA)	0.00%	-2.60%	1.44%	2.89%
Return on Common Equity (ROCE)	0.00%	-131.53%	35.83%	51.59%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	173	-437	283	410
NOPAT Margin	4.20%	-10.45%	6.58%	9.41%
Net Nonoperating Expense Percent (NNEP)	0.00%	-23.75%	8.52%	11.16%
Return On Investment Capital (ROIC_SIMPLE)	-	-13.52%	8.95%	12.97%
Cost of Revenue to Revenue	80.52%	80.08%	76.31%	75.63%
SG&A Expenses to Revenue	14.22%	13.98%	12.10%	11.78%
R&D to Revenue	1.55%	1.91%	1.44%	1.61%
Operating Expenses to Revenue	15.77%	15.89%	13.54%	13.39%
Earnings before Interest and Taxes (EBIT)	177	179	458	459
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	436	433	745	736
Valuation Ratios	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	11.23	6.99
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.00	0.00	0.57	0.65
Price to Earnings (P/E)	0.00	0.00	30.73	17.39
Dividend Yield	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	3.25%	5.75%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	1.88	1.95
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	1.11	1.14
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	6.41	6.72
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	10.42	10.77
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	16.86	12.06
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	13.88	13.88
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	11.70	11.92
Leverage & Solvency	-	-	-	-
Debt to Equity	0.00	13.58	13.18	6.86
Long-Term Debt to Equity	0.00	13.23	12.82	6.65
Financial Leverage	0.00	10.98	10.67	7.10
Leverage Ratio	0.00	25.68	25.25	17.92
Compound Leverage Factor	0.00	12.77	6.89	7.38
Debt to Total Capital	0.00%	93.14%	92.95%	87.28%
Short-Term Debt to Total Capital	0.00%	2.35%	2.56%	2.72%
Long-Term Debt to Total Capital	0.00%	90.79%	90.39%	84.56%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.09%	0.13%	-0.03%
Common Equity to Total Capital	0.00%	6.77%	6.92%	12.75%
Debt to EBITDA	0.00	6.96	3.95	3.75
Net Debt to EBITDA	0.00	5.63	3.10	2.89
Long-Term Debt to EBITDA	0.00	6.79	3.84	3.63
Debt to NOPAT	0.00	-6.89	10.38	6.73
Net Debt to NOPAT	0.00	-5.57	8.16	5.19
Long-Term Debt to NOPAT	0.00	-6.72	10.10	6.52
Altman Z-Score	0.00	0.00	1.38	1.41
Noncontrolling Interest Sharing Ratio	0.00%	1.35%	1.57%	0.48%
Liquidity Ratios	-	-	-	-
Current Ratio	0.00	1.05	1.02	0.96
Quick Ratio	0.00	0.59	0.58	0.53
Cash Flow Metrics	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-3,096	408	415
Operating Cash Flow to CapEx	282.47%	268.94%	273.02%	320.72%
Free Cash Flow to Firm to Interest Expense	0.00	-34.40	1.23	1.54
Operating Cash Flow to Interest Expense	8.84	3.94	1.03	1.32
Operating Cash Flow Less CapEx to Interest Expense	5.71	2.48	0.65	0.91
Efficiency Ratios	-	-	-	-
Asset Turnover	0.00	0.73	0.77	0.78
Accounts Receivable Turnover	0.00	5.92	6.68	7.70
Inventory Turnover	0.00	10.07	10.27	10.15
Fixed Asset Turnover	0.00	8.94	9.14	8.84
Accounts Payable Turnover	0.00	6.64	6.15	5.58
Days Sales Outstanding (DSO)	0.00	61.65	54.60	47.41
Days Inventory Outstanding (DIO)	0.00	36.26	35.56	35.97
Days Payable Outstanding (DPO)	0.00	54.99	59.39	65.45
Cash Conversion Cycle (CCC)	0.00	42.92	30.77	17.92
Capital & Investment Metrics	-	-	-	-
Invested Capital	0.00	2,659	2,534	2,529
Invested Capital Turnover	0.00	3.15	1.66	1.72
Increase / (Decrease) in Invested Capital	0.00	2,659	-125	-5.00
Enterprise Value (EV)	0.00	0.00	4,774	4,942
Market Capitalization	0.00	0.00	2,459	2,816
Book Value per Share	$0.00	$3.10	$3.02	$5.45
Tangible Book Value per Share	$0.00	($33.54)	($31.47)	($27.78)
Total Capital	0.00	3,236	3,163	3,160
Total Debt	0.00	3,014	2,940	2,758
Total Long-Term Debt	0.00	2,938	2,859	2,672
Net Debt	0.00	2,437	2,311	2,127
Capital Expenditures (CapEx)	97	132	126	111
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	-413	-521	-620
Debt-free Net Working Capital (DFNWC)	0.00	164	108	11
Net Working Capital (NWC)	0.00	88	27	-75
Net Nonoperating Expense (NNE)	75	-289	202	248
Net Nonoperating Obligations (NNO)	0.00	2,437	2,311	2,127
Total Depreciation and Amortization (D&A)	259	254	287	277
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	-9.87%	-12.10%	-14.24%
Debt-free Net Working Capital to Revenue	0.00%	3.92%	2.51%	0.25%
Net Working Capital to Revenue	0.00%	2.10%	0.63%	-1.72%
Earnings Adjustments	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$1.11	$2.20
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	72.20M	73.50M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$1.08	$2.14
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	74.20M	75.60M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	73.04M	73.56M
Normalized Net Operating Profit after Tax (NOPAT)	173	184	283	410
Normalized NOPAT Margin	4.20%	4.40%	6.58%	9.41%
Pre Tax Income Margin	3.54%	2.13%	2.90%	4.34%
Debt Service Ratios	-	-	-	-
EBIT to Interest Expense	5.71	1.99	1.38	1.70
NOPAT to Interest Expense	5.59	-4.86	0.85	1.52
EBIT Less CapEx to Interest Expense	2.58	0.52	1.00	1.29
NOPAT Less CapEx to Interest Expense	2.46	-6.33	0.47	1.11
Payout Ratios	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	17.28%

This table displays calculated financial ratios and metrics derived from NCR Atleos' official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	73,904,136.00	73,561,203.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	73,904,136.00	73,561,203.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	1.00	0.30
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	0.00%	6.49%	3.85%	0.56%	0.37%	-6.67%	2.22%	4.47%	4.27%	6.54%
EBITDA Growth	0.00%	0.00%	17.46%	30.71%	15.09%	2,700.00%	9.46%	11.48%	-6.56%	-13.85%	5.06%
EBIT Growth	0.00%	0.00%	13.64%	40.00%	13.54%	346.03%	24.00%	17.86%	-7.34%	-17.90%	7.87%
NOPAT Growth	0.00%	0.00%	27.96%	73.28%	231.87%	357.90%	17.22%	-11.69%	14.04%	98.94%	1.90%
Net Income Growth	0.00%	0.00%	-121.62%	-44.23%	135.09%	120.56%	300.00%	51.72%	30.00%	90.00%	69.23%
EPS Growth	0.00%	0.00%	-121.57%	-45.33%	134.15%	117.97%	309.09%	46.34%	21.43%	94.00%	52.63%
Operating Cash Flow Growth	0.00%	0.00%	23.33%	-88.75%	-27.21%	900.00%	-16.89%	-355.56%	-76.64%	188.75%	-107.32%
Free Cash Flow Firm Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	106.22%	104.09%	101.70%	-16.18%	-109.62%
Invested Capital Growth	0.00%	0.00%	0.00%	0.00%	0.00%	-4.70%	-3.85%	-0.76%	1.70%	-0.20%	2.81%
Revenue Q/Q Growth	2.60%	2.44%	-4.37%	2.86%	-0.65%	1.76%	-11.55%	12.65%	1.54%	2.50%	-9.23%
EBITDA Q/Q Growth	13.57%	-94.97%	469.23%	23.65%	0.00%	17.89%	-31.06%	25.93%	-16.18%	16.37%	-16.58%
EBIT Q/Q Growth	20.00%	-165.63%	266.67%	49.33%	-2.68%	33.62%	-43.98%	41.94%	-23.48%	31.68%	-27.82%
NOPAT Q/Q Growth	-205.22%	132.79%	105.71%	88.31%	-19.92%	16.99%	-40.92%	41.87%	3.41%	98.94%	-67.52%
Net Income Q/Q Growth	-209.62%	-215.79%	95.12%	462.50%	-31.03%	60.87%	-67.35%	175.00%	-40.91%	192.31%	-71.05%
EPS Q/Q Growth	-209.33%	-212.20%	95.30%	472.73%	-31.71%	43.75%	-63.49%	160.87%	-43.33%	185.29%	-70.10%
Operating Cash Flow Q/Q Growth	83.75%	-94.56%	1,750.00%	-93.92%	1,088.89%	-25.23%	53.75%	-118.70%	208.70%	824.00%	-103.90%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	1.42%	1.26%	108.43%	-25.54%	-35.15%	-58.90%	315.82%	-108.45%
Invested Capital Q/Q Growth	0.00%	0.00%	-2.27%	0.30%	-1.94%	-1.86%	-1.83%	3.53%	0.50%	-3.69%	2.61%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	21.93%	17.66%	21.05%	23.24%	23.86%	26.07%	23.98%	22.92%	24.17%	26.28%	22.44%
EBITDA Margin	14.90%	0.73%	14.10%	16.94%	17.06%	20.42%	16.53%	18.48%	15.25%	17.32%	15.92%
Operating Margin	8.53%	2.47%	6.86%	10.00%	10.62%	12.58%	9.80%	10.87%	9.81%	13.23%	8.05%
EBIT Margin	9.00%	-5.76%	7.14%	10.37%	10.16%	14.13%	9.49%	11.96%	9.01%	11.58%	9.20%
Profit (Net Income) Margin	-5.34%	-16.47%	-0.76%	2.69%	1.86%	3.37%	1.63%	3.99%	2.32%	6.61%	2.11%
Tax Burden Percent	-63.33%	130.43%	200.00%	87.88%	66.67%	62.71%	61.54%	69.84%	78.79%	113.43%	66.67%
Interest Burden Percent	93.75%	219.05%	-5.33%	29.46%	27.52%	38.06%	27.96%	47.73%	32.67%	50.38%	34.38%
Effective Tax Rate	163.33%	0.00%	0.00%	12.12%	33.33%	37.29%	38.46%	30.16%	21.21%	-13.43%	33.33%
Return on Invested Capital (ROIC)	0.00%	2.72%	15.56%	28.67%	23.57%	13.08%	9.94%	12.36%	12.79%	25.81%	9.27%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-5.44%	10.57%	23.14%	18.74%	10.99%	8.07%	10.65%	10.16%	21.46%	7.74%
Return on Net Nonoperating Assets (RNNOA)	0.00%	-59.71%	86.07%	219.56%	165.96%	117.29%	65.43%	81.97%	79.06%	152.41%	51.03%
Return on Equity (ROE)	0.00%	-56.99%	101.63%	248.23%	189.53%	130.37%	75.38%	94.34%	91.84%	178.22%	60.30%
Cash Return on Invested Capital (CROIC)	0.00%	-116.45%	0.00%	0.00%	0.00%	15.72%	16.53%	12.93%	10.38%	16.38%	12.89%
Operating Return on Assets (OROA)	0.00%	-4.23%	5.26%	7.73%	7.59%	10.83%	7.00%	8.82%	6.81%	9.00%	7.15%
Return on Assets (ROA)	0.00%	-12.09%	-0.56%	2.00%	1.39%	2.58%	1.20%	2.94%	1.75%	5.14%	1.64%
Return on Common Equity (ROCE)	0.00%	-56.22%	100.21%	247.24%	190.98%	128.32%	74.44%	93.87%	92.00%	177.37%	60.03%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	-62.54%	0.00%	0.00%	0.00%	42.18%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-58	19	50	95	76	87	59	84	87	172	56
NOPAT Margin	-5.40%	1.73%	4.80%	8.79%	7.08%	7.89%	6.03%	7.59%	7.73%	15.01%	5.37%
Net Nonoperating Expense Percent (NNEP)	0.00%	8.16%	5.00%	5.53%	4.83%	2.09%	1.88%	1.71%	2.63%	4.35%	1.53%
Return On Investment Capital (ROIC_SIMPLE)	-	0.58%	1.56%	2.91%	2.33%	2.74%	1.85%	2.58%	2.71%	5.46%	1.76%
Cost of Revenue to Revenue	78.07%	82.34%	78.95%	76.76%	76.14%	73.93%	76.02%	77.08%	75.83%	73.72%	77.56%
SG&A Expenses to Revenue	15.00%	12.81%	12.57%	12.22%	11.84%	11.85%	12.45%	10.51%	12.76%	11.49%	12.46%
R&D to Revenue	1.59%	2.38%	1.62%	1.02%	1.40%	1.64%	1.73%	1.54%	1.61%	1.57%	1.92%
Operating Expenses to Revenue	16.59%	15.19%	14.19%	13.24%	13.23%	13.49%	14.18%	12.05%	14.36%	13.05%	14.38%
Earnings before Interest and Taxes (EBIT)	96	-63	75	112	109	155	93	132	101	133	96
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	159	8.00	148	183	183	224	162	204	171	199	166
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	7.79	7.82	11.23	7.01	5.99	8.77	6.99	8.10
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.00	0.00	0.00	0.45	0.48	0.57	0.45	0.49	0.67	0.65	0.73
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	30.73	16.61	16.00	23.14	17.39	18.86
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	3.25%	6.02%	6.25%	4.32%	5.75%	5.30%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	1.65	1.70	1.88	1.65	1.67	1.98	1.95	2.08
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	1.01	1.02	1.11	0.98	1.02	1.20	1.14	1.22
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	9.58	9.00	6.41	6.72	6.79	8.37	6.72	7.26
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	18.20	18.80	10.42	8.59	8.61	10.63	10.77	11.60
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	20.22	19.50	16.86	12.86	13.65	16.51	12.06	13.48
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	13.88	16.11	13.88	13.09	15.19	25.31	13.88	24.13
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	11.70	9.81	12.85	19.19	11.92	16.38
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	13.58	10.23	11.97	11.43	13.18	10.48	8.23	8.67	6.86	7.03
Long-Term Debt to Equity	0.00	13.23	9.95	11.64	11.09	12.82	10.19	8.00	8.43	6.65	6.83
Financial Leverage	0.00	10.98	8.15	9.49	8.86	10.67	8.11	7.70	7.78	7.10	6.60
Leverage Ratio	0.00	25.68	20.13	22.97	21.94	25.25	20.38	19.20	19.22	17.92	16.88
Compound Leverage Factor	0.00	56.26	-1.07	6.77	6.04	9.61	5.70	9.16	6.28	9.03	5.80
Debt to Total Capital	0.00%	93.14%	91.10%	92.29%	91.95%	92.95%	91.29%	89.17%	89.66%	87.28%	87.54%
Short-Term Debt to Total Capital	0.00%	2.35%	2.48%	2.58%	2.70%	2.56%	2.54%	2.49%	2.50%	2.72%	2.52%
Long-Term Debt to Total Capital	0.00%	90.79%	88.62%	89.71%	89.25%	90.39%	88.75%	86.67%	87.16%	84.56%	85.03%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.09%	0.12%	0.03%	-0.06%	0.13%	0.09%	0.06%	0.03%	-0.03%	0.00%
Common Equity to Total Capital	0.00%	6.77%	8.78%	7.68%	8.11%	6.92%	8.62%	10.77%	10.31%	12.75%	12.46%
Debt to EBITDA	0.00	6.96	7.79	6.65	6.15	3.95	4.69	4.51	4.63	3.75	3.74
Net Debt to EBITDA	0.00	5.63	6.20	5.27	4.76	3.10	3.62	3.52	3.70	2.89	2.96
Long-Term Debt to EBITDA	0.00	6.79	7.58	6.46	5.97	3.84	4.56	4.39	4.50	3.63	3.63
Debt to NOPAT	0.00	-6.89	-2.46	14.03	13.32	10.38	8.98	9.07	9.13	6.73	6.94
Net Debt to NOPAT	0.00	-5.57	-1.96	11.12	10.32	8.16	6.92	7.08	7.30	5.19	5.48
Long-Term Debt to NOPAT	0.00	-6.72	-2.39	13.64	12.93	10.10	8.73	8.82	8.87	6.52	6.74
Altman Z-Score	0.00	0.00	0.00	1.09	1.11	1.20	1.08	1.12	1.22	1.22	1.27
Noncontrolling Interest Sharing Ratio	0.00%	1.35%	1.39%	0.40%	-0.76%	1.57%	1.24%	0.50%	-0.17%	0.48%	0.45%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.00	1.05	1.05	1.07	1.07	1.02	1.03	1.05	1.02	0.96	0.98
Quick Ratio	0.00	0.59	0.58	0.58	0.57	0.58	0.54	0.54	0.55	0.53	0.54
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	0.00	-2,575	-2,538	-2,506	212	160	104	43	177	-15
Operating Cash Flow to CapEx	306.25%	17.02%	493.33%	28.13%	324.24%	258.06%	300.00%	-65.71%	80.65%	825.00%	-24.32%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	-32.59	-32.13	-31.72	2.20	2.39	1.50	0.63	2.69	-0.24
Operating Cash Flow to Interest Expense	24.50	0.00	1.87	0.11	1.35	0.83	1.84	-0.33	0.37	3.50	-0.14
Operating Cash Flow Less CapEx to Interest Expense	16.50	0.00	1.49	-0.29	0.94	0.51	1.22	-0.84	-0.09	3.08	-0.73
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.73	0.74	0.75	0.75	0.77	0.74	0.74	0.76	0.78	0.78
Accounts Receivable Turnover	0.00	5.92	5.73	6.08	6.90	6.68	6.07	6.21	7.23	7.70	7.17
Inventory Turnover	0.00	10.07	10.26	10.31	9.62	10.27	9.33	8.84	8.87	10.15	9.29
Fixed Asset Turnover	0.00	8.94	9.23	9.40	9.40	9.14	9.04	9.12	9.15	8.84	8.94
Accounts Payable Turnover	0.00	6.64	6.39	5.94	6.19	6.15	5.97	5.54	6.06	5.58	5.89
Days Sales Outstanding (DSO)	0.00	61.65	63.65	60.08	52.93	54.60	60.16	58.80	50.51	47.41	50.93
Days Inventory Outstanding (DIO)	0.00	36.26	35.57	35.41	37.96	35.56	39.12	41.29	41.14	35.97	39.27
Days Payable Outstanding (DPO)	0.00	54.99	57.13	61.46	58.94	59.39	61.14	65.93	60.25	65.45	61.96
Cash Conversion Cycle (CCC)	0.00	42.92	42.09	34.03	31.95	30.77	38.15	34.16	31.40	17.92	28.25
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	0.00	2,659	2,625	2,633	2,582	2,534	2,524	2,613	2,626	2,529	2,595
Invested Capital Turnover	0.00	1.57	3.24	3.26	3.33	1.66	1.65	1.63	1.65	1.72	1.73
Increase / (Decrease) in Invested Capital	0.00	0.00	2,625	2,633	2,582	-125	-101	-20	44	-5.00	71
Enterprise Value (EV)	0.00	0.00	0.00	4,332	4,381	4,774	4,176	4,359	5,189	4,942	5,405
Market Capitalization	0.00	0.00	0.00	1,949	2,063	2,459	1,927	2,096	2,893	2,816	3,206
Book Value per Share	$0.00	$3.10	$3.95	$3.47	$3.65	$3.02	$3.77	$4.76	$4.48	$5.45	$5.38
Tangible Book Value per Share	$0.00	($33.54)	($31.76)	($31.85)	($31.43)	($31.47)	($30.52)	($29.09)	($29.19)	($27.78)	($27.68)
Total Capital	0.00	3,236	3,224	3,256	3,256	3,163	3,192	3,249	3,200	3,160	3,179
Total Debt	0.00	3,014	2,937	3,005	2,994	2,940	2,914	2,897	2,869	2,758	2,783
Total Long-Term Debt	0.00	2,938	2,857	2,921	2,906	2,859	2,833	2,816	2,789	2,672	2,703
Net Debt	0.00	2,437	2,338	2,382	2,320	2,311	2,246	2,261	2,295	2,127	2,199
Capital Expenditures (CapEx)	48	47	30	32	33	31	41	35	31	28	37
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	-413	-419	-413	-454	-521	-538	-466	-461	-620	-540
Debt-free Net Working Capital (DFNWC)	0.00	164	180	210	220	108	130	170	113	11	44
Net Working Capital (NWC)	0.00	88	100	126	132	27	49	89	33	-75	-36
Net Nonoperating Expense (NNE)	-0.63	199	58	66	56	50	43	40	61	96	34
Net Nonoperating Obligations (NNO)	0.00	2,437	2,338	2,382	2,320	2,311	2,246	2,261	2,295	2,127	2,199
Total Depreciation and Amortization (D&A)	63	71	73	71	74	69	69	72	70	66	70
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	-9.87%	-9.85%	-9.62%	-10.57%	-12.10%	-12.67%	-10.91%	-10.70%	-14.24%	-12.22%
Debt-free Net Working Capital to Revenue	0.00%	3.92%	4.23%	4.89%	5.12%	2.51%	3.06%	3.98%	2.62%	0.25%	1.00%
Net Working Capital to Revenue	0.00%	2.10%	2.35%	2.93%	3.07%	0.63%	1.15%	2.08%	0.77%	-1.72%	-0.81%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	($2.56)	($0.11)	$0.40	$0.33	$0.47	$0.23	$0.61	$0.35	$1.01	$0.30
Adjusted Weighted Average Basic Shares Outstanding	0.00	70.60M	71.60M	72.20M	72.30M	72.20M	73.10M	73.50M	73.70M	73.50M	73.60M
Adjusted Diluted Earnings per Share	$0.00	($2.56)	($0.11)	$0.39	$0.32	$0.46	$0.23	$0.60	$0.34	$0.97	$0.29
Adjusted Weighted Average Diluted Shares Outstanding	0.00	70.60M	71.60M	73.70M	74.50M	74.20M	75.20M	74.90M	76M	75.60M	75.60M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	72.12M	72.32M	72.49M	73.04M	73.45M	73.59M	73.90M	73.56M	73.78M
Normalized Net Operating Profit after Tax (NOPAT)	64	19	50	95	76	87	59	84	87	106	56
Normalized NOPAT Margin	5.97%	1.73%	4.80%	8.79%	7.08%	7.89%	6.03%	7.59%	7.73%	9.26%	5.37%
Pre Tax Income Margin	8.43%	-12.63%	-0.38%	3.06%	2.80%	5.38%	2.65%	5.71%	2.94%	5.83%	3.16%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	16.00	0.00	0.95	1.42	1.38	1.61	1.39	1.91	1.49	2.02	1.52
NOPAT to Interest Expense	-9.61	0.00	0.64	1.20	0.96	0.90	0.88	1.21	1.27	2.61	0.89
EBIT Less CapEx to Interest Expense	8.00	0.00	0.57	1.01	0.96	1.29	0.78	1.41	1.03	1.59	0.94
NOPAT Less CapEx to Interest Expense	-17.61	0.00	0.26	0.80	0.54	0.58	0.27	0.71	0.82	2.19	0.30
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	17.28%	25.73%

Financials Breakdown Chart

Key Financial Trends

Below is a concise, investor-friendly snapshot of NCR Atleos (NYSE:NATL) using the quarterly data provided for 2023–2025, focusing on trends over the most recent four years of operations. The emphasis is on revenue, profitability, cash flow, and balance-sheet risk that may matter to retail investors.

Revenue remained near the 1.0–1.15 billion range in the latest year, with Q4 2025 revenue at 1.149B and a gross margin of about 26% (Gross Profit 302M on 1.149B revenue), indicating steady topline performance.
Operating income strengthened in Q4 2025 to 152M, contributing to an improved operating margin versus the prior quarter (Q3 2025 operating income was 110M).
Q4 2025 produced a strong quarterly EPS for common shareholders (Basic EPS 1.01, Diluted EPS 0.97), supported by the higher pre-tax income and favorable tax treatment in that period.
Cash flow from continuing operating activities was robust in Q4 2025 at 231M, highlighting solid cash generation from core operations.
Free cash flow in Q4 2025 was positive and meaningful (approximately 194M: 231M from operations minus around 37M in capex), suggesting excess cash after sustaining investments.
Liquidity remained solid mid-2025 with cash and restricted cash totaling roughly 0.57–0.64 billion across recent quarters (e.g., 412M cash and 162M restricted cash in Q3 2025; 357M cash and 279M restricted cash in Q2 2025).
Capex has been modest and steady, running in the 30–50M per quarter range, aligning with the free-cash-flow narrative when combined with healthy operating cash flow.
R&D and SG&A are present and controlled: R&D typically around the mid-teens to low-tens of millions per quarter and SG&A around 130–140M in the latest year, contributing to a stable expense base as a share of revenue.
Leverage remains high: long-term debt around 2.8–2.9B and total liabilities around 5.3–5.5B, with equity only about 0.28–0.35B, indicating a material debt-load relative to equity.
Financing activities have been a drag on cash in several periods due to debt repayments and net outflows (e.g., net cash from financing activities negative in multiple quarters), which could pressure liquidity if earnings waver or working capital worsens.

05/16/26 02:00 PM ETAI Generated. May Contain Errors.

NCR Atleos Financials - Frequently Asked Questions

According to the most recent income statement we have on file, NCR Atleos' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

NCR Atleos' net income appears to be on an upward trend, with a most recent value of $162 million in 2025, rising from $98 million in 2022. The previous period was $81 million in 2024. Check out NCR Atleos' forecast to explore projected trends and price targets.

NCR Atleos' total operating income in 2025 was $478 million, based on the following breakdown:

Total Gross Profit: $1.06 billion
Total Operating Expenses: $583 million

Over the last 3 years, NCR Atleos' total revenue changed from $4.12 billion in 2022 to $4.35 billion in 2025, a change of 5.6%.

NCR Atleos' total liabilities were at $5.27 billion at the end of 2025, a 0.9% decrease from 2024, and a 3.9% decrease since 2023.

In the past 2 years, NCR Atleos' cash and equivalents has ranged from $339 million in 2023 to $456 million in 2025, and is currently $456 million as of their latest financial filing in 2025.

Over the last 3 years, NCR Atleos' book value per share changed from 0.00 in 2022 to 5.45 in 2025, a change of 545.3%.

Related Companies

Financial statements for NYSE:NATL last updated on 5/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

NCR Atleos (NATL) Financials

Financials Breakdown Chart

Key Financial Trends

NCR Atleos Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

NCR Atleos (NATL) Financials

Annual Income Statements for NCR Atleos

Quarterly Income Statements for NCR Atleos

Annual Cash Flow Statements for NCR Atleos

Quarterly Cash Flow Statements for NCR Atleos

Annual Balance Sheets for NCR Atleos

Quarterly Balance Sheets for NCR Atleos

Annual Metrics And Ratios for NCR Atleos

Quarterly Metrics And Ratios for NCR Atleos

Financials Breakdown Chart

Key Financial Trends

NCR Atleos Financials - Frequently Asked Questions

When does NCR Atleos' financial year end?

How has NCR Atleos' net income changed over the last 3 years?

What is NCR Atleos' operating income?

How has NCR Atleos' revenue changed over the last 3 years?

How much debt does NCR Atleos have?

How much cash does NCR Atleos have?

How has NCR Atleos' book value per share changed over the last 3 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools